Home | About us | Working Groups | CKD-MBD Working Group

CKD-MBD Working Group

Chronic Kidney Disease – Mineral and Bone Disorder Working Group

CKD-MBD Working Group

About us

The clinical “syndrome” of CKD-MBD has been recognized as an important contributor to morbidity and mortality throughout all stages of CKD. In the past, research centres have traditionally and individually focused on some isolated aspects of this newly recognized entity. Nevertheless, CKD-MBD is a complex interaction of multiple disturbances finally resulting in heterogeneous sequelae.

Large-scale cooperation between centres with a special interest in these matters is of key relevance in order to achieve a global and translational approach to the pathophysiology, prevention and treatment of CKD-MBD.

To this end, the CKD-MBD Working Group aims to work as a common platform for educational, intellectual and personal exchange to facilitate research in the field of Chronic Kidney Disease – Mineral and Bone Disorder.

Contacts & Resources

Join this Working Group

Join this Working Group

Becoming an Ordinary Member of an ERA Working Group is easy and free of charge. Ordinary Members must be ERA Members with a proven interest in the research area covered by the WG.

By joining the CKD-MBD Working Group you will receive updates on the Working Group initiatives: e-seminars, CMEs, research projects and networking opportunities.

To become an Ordinary Member and receive the CKD-MBD WG Newsletter take a few simple steps:
1. Login with your My ERA account
2. Go to MY PROFILE
3. Click on Working Groups
4. Select CKD-MBD from the list and click on Submit

Latest publications

CKD-MBD related publications in the ERA journals

The ERA acknowledges the high clinical and scientific relevance of the CKD-MBD syndrome, reflected by several key publications in the journals of our society. We hereby summarize the content of several recent important papers, providing a link to their abstracts.

EUROD initiative

EUROD (European Renal Osteodystrophy) is an initiative of the CKD-MDB Working Group.

Renal osteodystrophy (ROD) is a heterogeneous group of metabolic bone diseases complicating progressive chronic kidney disease (CKD). Bone biomarkers and bone imaging techniques may help to assess bone health and predict fractures in CKD but do have important inherent limitations. By informing on bone turnover and mineralization, a bone biopsy may help to guide prevention and treatment of ROD and its consequences.

According to a survey conducted in 2017 among European nephrologists, bone biopsies are performed rather exceptionally, both for clinical and research purposes. Obviously, clinical research in the field of ROD is threatened by vanishing clinical and pathological expertise, small patient cohorts and scientific isolation.

The European Renal Osteodystrophy (EUROD) initiative was created in 2016 to revitalize bone biopsy as a clinically useful tool in the diagnostic workup of CKD-MBD and to foster research on the epidemiology, implications, and reversibility of ROD. As such, the EUROD initiative aims to increase the understanding of ROD and ultimately to improve outcomes in CKD patients.

DISCOVER MORE

Winter Meetings

7th EUROD Winter Meeting – Webcasts are available here
January 17-19, 2024, Leuven, Belgium

6th EUROD Winter Meeting
January 19-21, 2023, Leuven, Belgium

5th EUROD Winter Meeting
January 20-21, 2022, Leuven, Belgium

4th EUROD Winter Meeting
January 14-15, 2021, Fully virtual

3rd EUROD Winter Meeting
January 18, 2020, Leuven, Belgium

2nd EUROD Winter Meeting
January 18, 2019, Leuven, Belgium

1st EUROD Winter Meeting
January 19, 2018, Leuven, Belgium

CKD-MBD Board

The CKD-MDB Board provides strategic direction to the working group. Board members enchance exchange of expertise and international cooperation.

Mathias Loberg Haarhaus

Mathias Loberg Haarhaus

Chair
Sweden
Daniel Cejka

Daniel Cejka

Vice-Chair
Austria

Carlo Alfieri, Italy

Antonio Bellasi, Switzerland

Martin de Borst, The Netherlands

Juan Miguel Diaz Tocados, Spain

Maria Fusaro, Italy

Mehmet Kanbay, Türkiye

Markus Ketteler, Germany

Smeeta Sinha, United Kingdom

Events organised by CKD-MBD

Kidneys, bones, and stones – managing kidney stones in the presence of CKD-MBD
Webcast is available here
May 8, 2024, Ljubljana, Slovenia

Nephrology Virtual Preceptorship: Fracture Prevention in CKD
December 4, 2020, Leuven, Belgium

EuReCa-M and CKD-MBD meeting
September 13-15, 2018, Thessaloniki, Greece